Pay in 4 interest-free payments of $5.19 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Intramuscular (or subcutaneous per the compounders label)
[1] In the SUSTAIN clinical trial programme , which evaluated semaglutide's efficacy and safety in thousands of patients with type 2 diabetes, anxiety was not reported as a statistically significant adverse event compared to placebo or active comparators
Integrate based on individual preferences and responses
Suboptimal glycaemic control and increasing weight gainmajor risk factors for blood glucose and CV complicationsare key concerns for this patient
A 30 person patient study of semaglutide by Lyons et al
US$ 24.96
US$ 28.43
US$ 28.31
US$ 26.66
